GRAVES' DISEASE

 

GRAVES' DISEASE

 

DEFINITION:

An autoimmune disease involving thyroidal and orbital tissue resulting in a goiter with thyrotoxicosis and ophthalmic abnormalities, respectively.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • all ages with increasing frequency with age and peak in the 3rd and 4th decades
  • risk factors:
    • F > M (4-5:1)
    • Yersinia enterocolitica, viral infections

PATHOGENESIS:

1. Background

  • an autoimmune process producing antibodies against antigens in the thyroid, orbit, and dermis resulting in a diffuse goiter, ophthalmopathy, and dermopathy, respectively, (skin rarely affected in childhood onset Graves')
  • exposure to Yersinia enterocolitica
    • has plasmid-encoded capsular proteins which bind TSH
    • antibodies against these proteins cross-react with TSH receptors
    • 72% of Graves' patients have antibodies to Yersinia
  • exposure to viral particles
    • patients unable to suppress production of antibodies after viral infection of thyroid
    • viral infection -> lymphocyte invasion -> gamma-interferon production -> MHC class II antigen on surface of thyroid follicular cells -> T cells secrete interleukins that induce activation and proliferation of nearby T and B cells -> antibodies which stimulate TSH receptors

CLINICAL FEATURES:

1. Thyroid Manifestations

1. Goiter (95%)

  • diffusely and symmetrically enlarged
  • thyroid bruits and thrills (increased blood flow)
  • growth acceleration with advanced bone age

2. Thyrotoxicosis

1. Symptoms

  • nervousness, heat intolerance, weight loss, irritability, fatigue, restless sleep, palpitation, decreased attention span, diarrhea, etc.

2. Signs

  • tremor, tachycardia, hypertension, warm skin, muscle weakness

2. Ophthalmic Manifestations (>50%)

  • proptosis (40%)
  • lid lag (22%)
  • lid retraction (16%)
  • stare (15%)
  • chemosis (7%)
  • conjunctival injection (7%)
  • periorbital edema (5%)
  • excess lacrimation (5%)
  • discomfort (3%)
  • diplopia (2%)

3. Rare Manifestations

  • Graves' dermopathy (pretibial myxederma)
    • violaceous indurated skin
  • heart failure, dysrhythmias
  • apathetic thyrotoxicosis

INVESTIGATIONS:

1. Serum

1. Thyroid Function Tests

  • increased T4 and free T3; decreased TSH

2. Serology

  • serum thyroid-stimulating immunoglobulins (TBI)
    • 95% sensitive and 96% specific
    • stimulated cAMP production in cultured rat thyroid follicular cells
  • antibodies to Yersinia enterocolitica

2. Imaging Studies

1. Thyroid Scan

  • diffuse increased 131I uptake

MANAGEMENT (see "Hyperthyroidism"):

1. Medical

1. Thioureylenes

  • propylthiouracil, carbimazole, methimazole

2. Antihypertensives

  • propranolol

2. Radiation

1. 131 Radioiodine

3. Surgery

1. Thyroidectomy

 

 

Pediatric Database - GRAVES' DISEASE

Pediatric Organization - Pedbase [at] Gmail.com